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Abstract 
The effect of P-alaxin on some neurobehavioural parameters was studied in Swiss white 
mice. 21 mice were randomly assigned to three groups (n=7) namely; control group, clini-
cal dose group and high dose group. Animals in control group received normal rat chow 
and standard feed ad libitum. Animals in the clinical dose group were given P-alaxin at a 
dose of 0.01mg/kg body weight while animals in the high dose group were given P-alaxin 
at a dose of 0.02mg/kg body weight. The results obtained showed that, in the open field 
maze test, the clinical dose and high dose groups showed significant increase (P<0.05) in 
stretch attend posture compared to control. Conversely, there was a significant decrease 
(P<0.05) in line crossings of high and clinical dose groups when compared to control. In 
the light/dark transition box test, the clinical and high dose groups showed a significant 
decrease (P<0.05) in the frequency of line crossings when compared to control. In the 
morris water maze test, the high and clinical dose groups showed a significant inncrease 
in frequency of swimming latency when compared to control group. From the total analy-
sis obtained, P-alaxin decreases locomotion and exploratory activities, it impairs motiva-
tion and the tendency to investigate the environment as well as reduction in visuospartial 
learning and memory. 
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Each tablet of P-alaxin contains 40mg of dihy-
droartemisinin and 320mg of Piperaquine phos-
phate. Dihydroartemisinin is a powerful plasmodi-
cide of malaria parasite gamete which is highly 
effective against all forms of malaria including mul-
ti-drug resistant malaria (Ashley et al., 2005). Di-
hydroartemisinin is the active metabolite of all ar-
temisinin compounds (artemisinin, artesunate and 
arthemeter) and is also available as a drug itself. It 
is a semi synthetic derivative of artemisinin – de-
rived anti-malarial drugs. It is in combination with 
piperaquine and has been shown to be equivalent 
to arthemeter/lumefantrine (Cabello et al., 2011).  
Dihydroartemisinin mainly intervenes with the 
membrane structures of trophozoitics (erythrocytic 
asexual forms) causing distended mitochondria, 
swollen nuclear membranes; dissociation of ribo-
somes from endoplasmic reticulum leading to cy-
toplasmic vacuolization and auto phagocytosis 
(Ashley, 2005). Piperaquine phosphate interferes 
with physiological function of the food vacuole 
membrane of the trophozoites leading to autopha-
gocytosis of the parasites (Cabello et al., 2011). 
P-alaxin has been widely used by humans as 
medicine for the treatment of Malaria in adults and 
children with reported side effect such as nausea 
or vomiting. However, there is paucity of 
knowledge on its effect on the nervous system 
particularly some neurobehavioral effects. Hence 
this study seeks to evaluate its effect on some 
neurobehavioral parameters. 
MATERIALS AND METHODS 
Experimental animals and protocol: Twenty 
one (21) Swiss white mice with  average weight of 
25g used in this study were purchased from the 
animal house of the Department of Pharmacology 
and housed in the animal house of the Depart-
ment of Physiology, University of Calabar.  They 
were randomly assigned on three groups (n=7) 
thus; Group 1: Control, group 2: Clinical dose, 
group 3: high dose. This was done after ethical 
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 approval was granted by the Animal Ethical Com-
mittee of the Faculty of Basic Medical Sciences, 
University of Calabar. 
Before the experiment, the animals were kept in 
the animal house in ventilated cages under nor-
mal temperature and 12/12 lights/dark cycle.  Ani-
mals were fed with normal ration of rodent chow 
from vital feeds each morning and water ad libi-
tum. P-alaxin was administered for 3 days before 
the commencement of the experiment. On each 
day of experiment, administration was carried out 
five minutes before commencement of each se-
quence of neurabavioural experiment. Those in 
the clinical dose group were given P-alaxin admin-
istered doses at a dosage of 0.01ml via oral route 
using the small graduated syringe attached with a 
feeding tube while those in high dose group were 
given P-alaxin administered doses at a dosage of 
0.02ml via oral route using the small graduated 
syringe attached with a feeding tube.  
Open field maze test: The standard open field 
test is commonly used to assess locomotor, ex-
ploratory and anxiety – like behaviour in laborato-
ry animals (rats/mice) as described by Bisong et 
al. (2018). This test is particularly useful in evalu-
ating the effects of anxolytic and anxiogenic 
drugs, locomotor responses to drug and as all 
behavioural responses to novelty. The open field 
area generally consists of an empty and bright 
square (or circular) arena surrounded by walls to 
prevent animal from escaping. The animal is usu-
ally placed in the center of the arena and its be-
haviour recorded over a chosen period (from 3 to 
15min). The open field task approaches the con-
flict between the innate fear that rodents have of 
the central area of a novel or brightly lit open field 
versus their desire to explore new environments. 
When anxious; the natural tendency of rodents is 
to prefer staying closed to the walls (thigmotaxic 
behaviour).  
Behaviours scored included: frequency of line 
crossings which is the number of times the animal 
crossed lines drawn on the floor of the open field 
maze. Walling frequency with which the animal 
stands on hind legs or leans against a wall of the 
box with its front paws. Stretch attend postures 
which is the frequency with which the animal 
demonstrates forward elongation of head and 
shoulders followed by retraction to original posi-
tion.  
Light and dark transition box test: The light/
dark transition box apparatus was used to meas-
ure some neurobehavioural parameters as de-
scribed by Bisong et al. (2017) located in a 2x5m 
laboratory room. Rats were carried into “the test 
room in their home cages and placed in the center 
of the white chamber facing the opening and were 
allowed to explore the apparatus for 5 minutes. An 
observer sitting quietly about 1m from the appa-
ratus recorded the behaviour of the animals in the 
box. A video camcorder located approximately 
150cm above the center of the maze also record-
ed the mouse’s behaviour. Behaviours were later 
scored by video play back using Hindsight for MS-
DOS version 1.5 Computer Software. After 5 
minutes, mice were removed from the box by the 
base of their trails and returned to their home 
cage. The maze was then with a solution of 70% 
ethyl alcohol and permitted to dry between tests. 
Behaviours scored included: frequency of line 
crossings which is the number of times the animal 
crossed lines drawn on the floor of the light and 
dark sides of the box. Rearing frequency with 
which the animal stands on hind legs or leans 
against a wall of the box with its front paws. 
Morris water maze test: The Morris water maze 
has been used extensively to study strain differ-
ences in spatial learning in mice and the effects of 
maze parameters on strain differences in spatial 
learning (Chapillon and Debouzie, 2000). Consid-
erable use has been made of the Morris water 
maze for studying spatial learning in transgenic 
and mutant mice the effects of brain injury on spa-
tial learning and the effects of drugs on spatial 
learning (Dalm et al., 2000). 
During the test period, each mouse was placed in 
a clean empty cage (no bedding); paper towel was 
torn and placed in the bottom of the cage to allow 
the mice to dry more quickly. This paper towel 
was replaced when it became completely wet. 
Mice were then run in squads of 5-6 with 10 
minutes between each trial for each mouse. Water 
from external sources like taps, bore holes etc 
was fetched and poured into a large round basin 
and powdered milk or chalk was grounded in pow-
der form and poured into the water.    
During acquisition training the water was adjusted 
appropriately such that the platform was covered 
by 1cm of water (invisible platform), the platform 
was placed in the centre of the North West quad-
rant. Each animal relieved 4 trials of 60 seconds 
per day. The starting positions of the animals were 
predetermined, which prevented any sequence of 
2 trials to be repeated by the animal during any 
other day. Possible start positions were at the 
boundaries of the quadrants (e.g West, North East 
or South). Each mouse was removed from its 
holding cage using a small clean 500ml plastic 
yogurt container to minimize handling stress. The 
animal was when placed into the water at the ap-
propriate start position, facing the center of the 
pool, the mouse was then permitted to explore the 
pool and to search for the hidden escape platform 
for 60 seconds. When the animal couldn’t locate 
the platform during the allotted time, the animal 
was guided onto the platform using the plastic 
container. Once on the platform, the mice were 
permitted to visually explore their surroundings for 
20 seconds at which point, the researcher picked 
up the mouse in the plastic container and returned 
Nku, C.O. et al. / J. Appl. & Nat. Sci. 10 (4): 1308-1313 (2018) 
1309 
 the mouse to the appropriate holding cage. The 
next mouse was then placed in the pool and the 
same procedure was followed. Each animal com-
pleted 4 trials per day over 3 days making a total 
of 12 trials of acquisition training. 
Reversal training began on day 4. The invisible 
platform was moved to the opposite quadrant 
(Southeast quadrant) and mice were again as-
signed to appropriate start positions; the same 
procedures as in acquisition training were again 
carried out during reversal training. Each of the 
animals completed 4 trials per day for 3days, a 
total of 12 trials of reversal training. 
A probe trial was conducted on the day 7. There 
was no escape platform in the maze at all. Each 
animal completed one trail of 60 seconds. Each 
mouse was placed in the maze from one of the 
four possible start positions and allowed to ex-
plore the pool. 
The visible platform task was conducted on day 8. 
The visible platform was placed in the Southeast 
quadrant of the pool. The same procedures as in 
acquisition and reversal training were carried out 
and mice completed 4 trails. 
During acquisition and reversal training the follow-
ing behaviours were measured;  
Swim latency which was the time it took to find 
and mount the escape platform. 
Thigmotaxic movement which is frequency by 
which the animal attempts to jump or leap out of 
the size of the circular pool of water. 
Proximity movement which is the frequency by 
which the animal swim to the escape plant form 
without climbing it. 
Statistical analysis: Data collected during the 
study were analyzed using analysis of variance 
(ANOVA) and post-hoc student Neuman – Keuls 
test. Results were presented as mean + SEM. 
RESULTS 
Effect of p-alaxin on frequency of rearing in 
the open field maze:  The mean frequency of 
rearing in the open field maze test for the control 
group, high dose group and clinical dose group 
were 3.00 + 2.47, 3.00 + 2.47 and 5.40 + 2.77/ 5 
mins. There was no significant difference between 
the clinical dose group and the control group. 
There was also no significant difference between 
the high dose group and the control group.  
Effect of p-alaxin on frequency of walling in 
the open field maze: The mean frequency of 
walling in the open field maze test for the control 
group, high dose group and clinical dose group 
were 19.80 + 3.54, 15.40 + 3.08, 14.80+0.58/ 
5mins. No significant difference existed in the 
mean values across the groups. 
Effect of p-alaxin on frequency of stretch at-
tend posture in the open field maze: The mean 
frequency of stretch attend posture in the open 
field maze test for the control group, high dose 
group and clinical dose group were 6.40 + 1.54, 
14.80 +0.58 and 8.20 + 1.32/ 5 mins. There was a 
significant increase (P<0.05) between the clinical 
dose group as well as the high dose group when 
compared to control group.  
Effect of p-alaxin on frequency of line cross-
ings in the open field maze: The mean frequency 
of line crossings in the open field maze test for the 
control group, high dose group and clinical dose 
group were 62.80 + 4.96, 50.80 -+ 4.55, 44.20+ 
3.93 /5 mins. There was a significant decrease 
(P<0.05) in the high dose and clinical dose groups 
when compared to control. 
Effect of p-alaxin on frequency of rearing in the 
light and dark transition box: The mean frequen-
cy of rearing in the light and dark transition box 
test for the control group, high dose group and 
clinical dose group were 29.00 + 5.50, 28.00 
+3.48, 23.29 + 4.36/ 5 mins. These results pre-
sented no significant difference between the clini-
cal dose group and the control group. There was 
no significant difference across the groups. 
Effect of p-alaxin on frequency of line cross-
ings in the light and dark transition box: The 
mean frequency of line crossings in the open field 
maze test for the control group, high dose group 
and clinical dose group were 65.82 + 4.76, 48.70 -
+ 3.55, 46.20+ 7.82 /5 mins. There was a signifi-
cant decrease (P<0.05) in the high dose and clini-
cal dose groups when compared to control. 
Effect of p-alaxin on frequency of swimming 
latency during acquisition training days 1-3 in 
the morris water maze: The mean frequency of 
swimming latency during acquisition training days 
in the morris water maze test for the control group, 
high dose group and clinical dose group were 
50.81 +2.37, 48.64 + 3.52 and 55.82 + 3.07 for 
day 1 to day 3 respectively. There was a signifi-
cant increase (P<0.05) in the high dose and clini-
cal dose groups when compared to control. 
Effect of p-alaxin on frequency of swimming 
latency during reversal training days 4-6 in the 
morris water maze: The mean frequency of swim-
ming latency during reversal training days in the 
morris water maze test for the control group, high 
dose group and clinical dose group were 21.43 
+3.99, 28.68 + 4.45 and 34.36 + 3.29 for day 4-6 
respectively. There was a significant increase 
(P<0.05) in the clinical dose group compared to 
the control group. There is no significant difference 
between (P<0.05) the high dose group and the 
control group.  
Effect of p-alaxin on frequency of swimming 
latency during the probe trial day in the morris 
water maze: The mean frequency of swimming 
latency during the probe trial day in the morris wa-
ter maze test for the control group, high dose 
group and clinical dose group were 1.00 + 0.31, 
0.86 +0.34, and 0.71 +0.36 respectively. There 
was no significant difference (P<0.05) across the 
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 groups. 
Effect of p-alaxin on frequency of swimming 
latency during the visible platform in the mor-
ris water maze: The mean frequency of swim-
ming latency during the visible platform day in the 
morris water maze test for the control group, high 
dose group and clinical dose group were 16.39 
+3.76, 11.46 + 0.81, 12.04 +3.03, There was a 
significant decrease (P<0.05) in the high dose and 
clinical dose groups when compared to control 
group. 
DISCUSSION 
This study observes the effect of p-alaxin on some 
neuro behavioural parameters in swiss albino 
mice. The neurobehavioural parameters consid-
ered in the study include locomotor activities 
which encompass locomotion and exploratory 
behaviours. Other parameters investigated in the 
study were fear and anxiety, learning and 
memory. 
The open field apparatus was used to study loco-
motion and exploratory behaviours. The light/dark 
transition boxes were used to study fear and anxi-
ety and the Morris water maze used to study 
-spatial learning and memory.  
The open field test has been used as a test that 
assesses locomotion behaviour. It provides simul-
taneous measures of locomotion, exploration as 
well as anxiety (Chi and Schmitt, 2005). Behav-
iours such as the number of line crosses and 
stretch attend postures are used as measures of 
exploration and anxiety. A high frequency of these 
behaviours indicates increased locomotion and 
exploration and or a lower level of anxiety. The 
frequency of line crosses (number of lines crossed 
per unit time) measures the horizontal locomotor 
behaviour. It represents the horizontal distance 
covered (Chi and Schmitt, 2005). The number of 
lines crossed following administration of 0.01mg 
of p-alaxin showed a significant decrease 
(P<0.05) from the control group. The high dose 
group also showed a significant decrease from the 
control group and recorded a decrease in the 
number of line crossings compared to the control 
group but higher than the clinical dose group. The 
drug showed a reduction in locomotion activity. 
The light/dark transition box test was also em-
ployed to study locomotion activity. It is a test for 
locomotion and exploratory behaviour. The fre-
quency of line crosses following administration 
with p-alaxin showed a significant decrease 
(P<0.05) when compared to the control group. 
This trend was also seen in the high dose group. 
The result of this experiment has shown that p-
alaxin has depressive or sedative effect as the 
drug decreased locomotion activity in both the 
open field and the light/dark transition box.  
The effects of treatment with the anti-malarial 
drug, p-alaxin on fear and anxiety related behav-
iour in mice was studied using the behaviours 
scored in the open field 5-minutes test and the 
light/dark transition box test. The high and clinical 
dose groups recorded an increase in the stretch 
attend posture compared to control. Stretch attend 
posture are risk-assessment behaviour which indi-
cate that the animal is hesitant to move from its 
present location to a new position (Gallagher, 
2008) and thus a high frequency of these postures 
indicates a higher level of anxiety. The hesitation 
of the animals to move from location to a new po-
sition may be due to sedative or depressive effect. 
The light/dark transition box has been used as a 
test of unconditioned anxiety and exploratory be-
haviour. The physiological basis of this test is cen-
tred on the conflict between exploring in a novel 
environment and avoidance of bright light (Bourin 
and Hascoet, 2003). The light chamber of the 
light/dark box is the aversive chamber and so, 
mice would normally spend more time in the dark 
chamber of the apparatus. 
However, an increase in exploratory behaviour in 
the light chamber (the aversive chamber) of the 
apparatus indicates decreased fear. This de-
creased fear (anxiolytic effect) could be caused by 
anxiolytic drugs/agents (Sandi, 2001).  
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Table 1. Neurobehavioural Parameters in swiss white mice of all the experimental groups. 
Parameters                                                       Groups Control High dose Clinical dose 
Frequency of rearing in the open field maze (Per 5min) 3.00±2.47 3.00±2.49 5.40±2.77 
Frequency of walling in the open field maze (Per 5min) 19.80±3.54 15.40±3.08 14.80±0.58 
Frequency of stretch attend posture in the open field maze (Per 
5min) 
6.40±1.54 14.80±0.58* 8.20±1.32* 
Frequency of line crossings in the open field maze (Per 5min) 62.80±4.96 50.80±4.55* 44.20±3.93* 
Frequency of rearing in the light and dark transition box (Per 
5min) 
29.00±5.50 28.00±3.48 23.29±4.36 
Frequency of line crossings in the light and dark transition box 
(Per 5min) 
65.82±4.76 48.70±3.55* 46.20±7.82* 
Frequency of swimming latency during acquisition training in 
Morris water maze 
50.80±2.37 48.64±3.52 55.82±3.07* 
Frequency of swimming latency during reversal training 21.43±3.99 28.68±4.45 34.36±3.39* 
Frequency of swimming latency during probe trial 1.00±0.31 0.86±0.34 0.71±0.36 
Frequency of swimming latency during the visible platform test 16.39±3.76 12.04±3.03* 11.46±0.81* 
Values are presented as Mean±SEM, n=7, *= significantly different from control at P<0.05 
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 The hidden-platform version of the Morris Water 
Maze is a test of visuo-spatial learning and 
memory performance of which is impaired by hip-
pocampal lesion (Chapillon and Debouzie, 2000). 
The visible-platform version of the Morris Water 
Maze on the other hand is a non-hippocampal 
task, which is dependent on the dorsal striatum 
(Caudate nucleus and putamen) of the basal gan-
glia (Chapillon and Debouzie, 2000). The visible 
(cued) platform uses a unique intra maze visual 
cue that is placed at the location of the escape 
platform whereas the visuo-spatial learning task 
uses extra maze cues. 
The swim latency was defined as the time it took 
the mice to locate the hidden platform in the visuo
-spatial learning task or the cued platform in the 
visible platform task, the shorter the swim latency, 
the better the learning process. Mice which 
learned faster were able to figure out the spatial 
location and position of the hidden platform earlier 
than their counter part, that is, within a very short 
time. Also, the steeper the gradient of swim laten-
cies in three days acquisition or reversal training, 
the better the learning. The clinical dose group 
showed a significant increase in swimming latency 
for high and clinical dose groups compared to the 
control group. There was however, a gradual de-
cline in the swim latency during the acquisition to 
day 3. It appears that the mice in all the groups 
were able to find the hidden platform at were 
therefore able to learn equally well during acquisi-
tion training. Even though there was significant 
differences among the groups, the fact is that 
there was gradual decline in the swim latency 
compared to control showing that there was some 
learning in the groups treated with the anti-
malarial drug as compared to control. Clinically, p-
alaxin can be taken to improve our memory. 
During reversal training, the high dose group 
showed a significant difference” from the control 
group, as the high dose group had a higher swim-
ming latency compared to the control group on the 
sixth day, the clinical dose group maintained a low 
swimming latency from the fourth to sixth day. 
Since, shorter latencies mean shorter time to lo-
cate the hidden platform and hence better learn-
ing ability, the mice treated with the anti-malarial 
drug had improved learning during reversal train-
ing. It can be inferred at this juncture that p-alaxin 
treated mice did better in the swim latency.  
Visuo-spatial memory was assessed during the 
probe trail in the morris-water maze task. During 
the probe trial, the hidden platform was removed 
and mice were introduced into the maze and al-
lowed to explore for 60 seconds, during which the 
quadrant duration (the time spent exploring each 
quadrant) were recorded. It is expected that mice 
which have a good memory would spend more 
time exploring the guardant which had the hidden 
platform during the reversal training, in this case, 
the South-east (SE) guardant. Mice treated with p-
alaxin, showed no significance difference between 
the clinical dose group and the control group, the 
high dose group when compared to the control 
group also showed no significant difference and 
had a higher swimming latency. There was a sig-
nificant increase (P<0.05) in the time spent in the 
SE quadrant. This increase in the SE quadrant 
duration implies that there was improvement in 
memory. This is consistent with the learning curve 
obtained during the reversal training. 
The cued version of the Morris-water maze as-
sesses cued learning and visual integrity of the 
animals tested. Impairment in performance in the 
hidden platform task may be due to some brain 
lesions or drugs which may affect the motivation 
to escape or sensory motor factors rather than 
spatial learning. This cueing procedure, in which 
the escape platform protrudes above the water 
surface, provides a control for this (Morris, 1984). 
Here also, the swim latencies were used for the 
comparisons. Shorter swim latencies in the visible 
platform task indicate improved cued learning. 
The reverse also holds. Swimming latency during 
visible platform task of the water maze task, the 
clinical dose group showed a significant difference 
to the control group, as the clinical dose group 
had a higher swimming latency compared to the 
control group and the high dose group also 
showed a significant difference (P<0.05) when 
compared to the control group and having a high-
er swimming latency than both the clinical dose 
group and the control group. Administration of p-
alaxin improved place learning in much the same 
way as there was improved reversal learning. The 
results in this study showed that p-alaxin improved 
memory in mice.  
From the result obtained on the locomotion and 
exploratory behaviour in mice, the treatment with 
the anti-malarial drug, p-alaxin decreased both 
locomotion and exploratory activity. The drug is 
sedative. The drug impaired motivation. The drug 
also tends to increase fear and anxiety. Further-
more, results in this study also showed that p-
alaxin decreases visuo-spartial learning and 
memory in mice. 
Conclusion 
From the results obtained from this study, it can 
be concluded that malaria treatment with p-alaxin 
decreases locomotion and exploratory activity in 
swiss mice. P-alaxin also impairs motivation as 
well as reduction in visuospartial learning and 
memory. More so, P-alaxin also increases fear 
and anxiety. If these results are to be applicable to 
humans, then this calls for concern and caution as 
consistent use of p-alaxin for the treatment of ma-
laria may pose debilitating consequences on hu-
mans as seen from the results of this study. 
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